SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001808805-23-000039
Filing Date
2023-04-27
Accepted
2023-04-27 16:00:53
Documents
5
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A nautilusdef14a20230614a.htm DEF 14A 512039
2 GRAPHIC nautilus_primarylogoxblue.jpg GRAPHIC 291090
3 GRAPHIC nautilusproxycard001.jpg GRAPHIC 121894
4 GRAPHIC nautilusproxycard002.jpg GRAPHIC 115445
5 GRAPHIC sujalsignature.jpg GRAPHIC 6720
  Complete submission text file 0001808805-23-000039.txt   1224181
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 981541723 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39434 | Film No.: 23856575
SIC: 3826 Laboratory Analytical Instruments